115 related articles for article (PubMed ID: 16334774)
1. Efficacy of STI571 for a patient with metastatic gastrointestinal stromal tumor.
Sasaki Y; Niwa Y; Ando N; Otsuka Y; Ohmiya N; Hirooka Y; Itoh A; Furuta S; Goto H
Hepatogastroenterology; 2005; 52(66):1764-7. PubMed ID: 16334774
[TBL] [Abstract][Full Text] [Related]
2. Primary omental gastrointestinal stromal tumor (GIST).
Todoroki T; Sano T; Sakurai S; Segawa A; Saitoh T; Fujikawa K; Yamada S; Hirahara N; Tsushima Y; Motojima R; Motojima T
World J Surg Oncol; 2007 Jun; 5():66. PubMed ID: 17565683
[TBL] [Abstract][Full Text] [Related]
3. A successful case of oral molecularly targeted therapy with imatinib for peritoneal metastasis of a gastrointestinal stromal tumor.
Kanda T; Ohashi M; Makino S; Kaneko K; Matsuki A; Nakagawa S; Hatakeyama K
Int J Clin Oncol; 2003 Jun; 8(3):180-3. PubMed ID: 12851843
[TBL] [Abstract][Full Text] [Related]
4. Targeted molecular therapy for cancer: the application of STI571 to gastrointestinal stromal tumor.
Dematteo RP; Maki RG; Antonescu C; Brennan MF
Curr Probl Surg; 2003 Mar; 40(3):144-93. PubMed ID: 12571542
[No Abstract] [Full Text] [Related]
5. Fatal abdominal sarcomatosis secondary to gastrointestinal stromal tumor with bland histology.
Elshenawy YM; Ganote CE; Al-Abbadi MA
Saudi Med J; 2009 Nov; 30(11):1469-72. PubMed ID: 19882063
[TBL] [Abstract][Full Text] [Related]
6. Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate.
Rutkowski P; Nowecki Z; Nyckowski P; Dziewirski W; Grzesiakowska U; Nasierowska-Guttmejer A; Krawczyk M; Ruka W
J Surg Oncol; 2006 Mar; 93(4):304-11. PubMed ID: 16496358
[TBL] [Abstract][Full Text] [Related]
7. [A gastric stromal tumor (GIST) with a prolonged partial response to a reduced dose of imatinib mesilate].
Nakatani K; Tanabe S; Nishimura K; Shimoda T; Azuma M; Katada C; Sasaki T; Higuchi K; Koizumi W; Saigenji K
Gan To Kagaku Ryoho; 2006 Jul; 33(7):997-1000. PubMed ID: 16835496
[TBL] [Abstract][Full Text] [Related]
8. Imatinib-induced hand-foot syndrome in a patient with metastatic gastrointestinal stromal tumor.
Battistella M; Frémont G; Vignon-Pennamen MD; Gornet JM; Dubertret L; Viguier M
Arch Dermatol; 2008 Oct; 144(10):1400-2. PubMed ID: 18936416
[No Abstract] [Full Text] [Related]
9. Metastatic gastrointestinal stromal tumor with long-term response after treatment with concomitant radiotherapy and imatinib mesylate.
Boruban C; Sencan O; Akmansu M; Atik ET; Ozbek S
Anticancer Drugs; 2007 Sep; 18(8):969-72. PubMed ID: 17667604
[TBL] [Abstract][Full Text] [Related]
10. [Metastatic gastrointestinal stromal tumors responded to the treatment with STI571 after polysurgery for recurrent lesions--report of two cases].
Sasaki K; Doi T; Matsumoto G; Tsuruta K; Okamoto A; Funada N
Gan To Kagaku Ryoho; 2003 Jul; 30(7):1021-5. PubMed ID: 12894723
[TBL] [Abstract][Full Text] [Related]
11. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors.
Kobayashi K; Szklaruk J; Trent JC; Ensor J; Ahrar K; Wallace MJ; Madoff DC; Murthy R; Hicks ME; Gupta S
Am J Clin Oncol; 2009 Dec; 32(6):574-81. PubMed ID: 19636238
[TBL] [Abstract][Full Text] [Related]
12. Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression.
Liegl B; Hornick JL; Antonescu CR; Corless CL; Fletcher CD
Am J Surg Pathol; 2009 Feb; 33(2):218-26. PubMed ID: 18830121
[TBL] [Abstract][Full Text] [Related]
13. [Successful treatment of huge peritoneal metastasis from duodenal gastrointestinal stromal tumor resistant for imatinib mesylate].
Sakakura C; Kumano T; Mizuta Y; Yamaoka N; Sagara Y; Hagiwara A; Otsuji E
Gan To Kagaku Ryoho; 2007 Nov; 34(12):2144-6. PubMed ID: 18219926
[TBL] [Abstract][Full Text] [Related]
14. [A case of gastric gastrointestinal stromal tumor operated after low-dose chemotherapy with imatinib mesylate].
Hori K; Hanada N; Kusano S; Tsurumoto Y; Sakashita N; Uchino R
Gan To Kagaku Ryoho; 2008 Oct; 35(10):1749-51. PubMed ID: 18931581
[TBL] [Abstract][Full Text] [Related]
15. Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST).
Fiore M; Palassini E; Fumagalli E; Pilotti S; Tamborini E; Stacchiotti S; Pennacchioli E; Casali PG; Gronchi A
Eur J Surg Oncol; 2009 Jul; 35(7):739-45. PubMed ID: 19110398
[TBL] [Abstract][Full Text] [Related]
16. [A patient with metastatic gastrointestinal stromal tumor who responded to STI571].
Terashima M; Abe K; Takeda Y; Saito K; Uesugi N; Kato K; Sato K; Maekawa T
Gan To Kagaku Ryoho; 2002 Apr; 29(4):607-10. PubMed ID: 11977548
[TBL] [Abstract][Full Text] [Related]
17. [Imatinib mesylate in the treatment of advanced gastrointestinal stromal tumors].
Wan DS; Wu XJ; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Ding PR
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(43):3064-7. PubMed ID: 17288838
[TBL] [Abstract][Full Text] [Related]
18. Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.
Blanke CD; Rankin C; Demetri GD; Ryan CW; von Mehren M; Benjamin RS; Raymond AK; Bramwell VH; Baker LH; Maki RG; Tanaka M; Hecht JR; Heinrich MC; Fletcher CD; Crowley JJ; Borden EC
J Clin Oncol; 2008 Feb; 26(4):626-32. PubMed ID: 18235122
[TBL] [Abstract][Full Text] [Related]
19. Treatment with STI571, a tyrosine kinase inhibitor, for gastrointestinal stromal tumor with peritoneal dissemination and multiple liver metastases.
Yamamoto S; Kubo S; Shuto T; Yamamoto T; Hirohashi K; Tanaka H; Takemura S; Kanazawa A; Kinoshita H
J Gastroenterol; 2003; 38(9):896-9. PubMed ID: 14564636
[TBL] [Abstract][Full Text] [Related]
20. Persistent cutaneous hyperpigmentation after tyrosine kinase inhibition with imatinib for GIST.
Alexandrescu DT; Dasanu CA; Farzanmehr H; Kauffman L
Dermatol Online J; 2008 Jul; 14(7):7. PubMed ID: 18718191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
